AKCA

Transfer...

Symbol:

NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Distressed
# of Employee: 100 / Fiscal Year End: 2018-12-31 / Stock Type: —
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.

Competitors | QuarterReport

Competitors List | Company Detail

AKCA |

Finance Benchmark

Key Ratio Benchmark | Key Ratio B | Income B | Balance B | Cash B | Top

ROE

ReportDate	(AKCA)	(AKCA)
2017-12-25	-20.2	0
2018-12-25	-73.7	0

ROE Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-264.8	0

FCFMargin

ReportDate	(AKCA)	(AKCA)
2017-12-25	-65.6	0
2018-12-25	-314.5	0

FCFMargin Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-379.4	0

FCFPerShare

ReportDate	(AKCA)	(AKCA)
2017-12-25	-119.6	0
2018-12-25	-250.7	0

FCFPerShare Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-109.6	0

EquityPerShare

ReportDate	(AKCA)	(AKCA)
2017-12-25	593.6	0
2018-12-25	340.1	0

EquityPerShare Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-42.7	0

Income Statement Benchmark | Key Ratio B | Income B | Balance B | Cash B | Top

Revenue

ReportDate	(AKCA)	(AKCA)
2017-12-25	5520900k	0
2018-12-25	6486700k	0

Revenue Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	17.5	0

ContinuousOperatingIncome

ReportDate	(AKCA)	(AKCA)
2017-12-25	-10975100k	0
2018-12-25	-22582100k	0

ContinuousOperatingIncome Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-105.8	0

NetIncome

ReportDate	(AKCA)	(AKCA)
2017-12-25	-10975100k	0
2018-12-25	-22582100k	0

NetIncome Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-105.8	0

DilutedShares

ReportDate	(AKCA)	(AKCA)
2017-12-25	3026276800.0	0
2018-12-25	8136580100.0	0

DilutedShares Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	168.9	0

ProfitMargin

ReportDate	(AKCA)	(AKCA)
2017-12-25	100.0	0
2018-12-25	81.9	0

ProfitMargin Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-18.1	0

ContinuousNetMargin

ReportDate	(AKCA)	(AKCA)
2017-12-25	-198.8	0
2018-12-25	-348.1	0

ContinuousNetMargin Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-75.1	0

NetMargin

ReportDate	(AKCA)	(AKCA)
2017-12-25	-198.8	0
2018-12-25	-348.1	0

NetMargin Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-75.1	0

Balance Sheet Benchmark | Key Ratio B | Income B | Balance B | Cash B | Top

Equity

ReportDate	(AKCA)	(AKCA)
2017-12-25	17963300k	0
2018-12-25	27672400k	0

Equity Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	54.0	0

TotalLiability

ReportDate	(AKCA)	(AKCA)
2017-12-25	8917100k	0
2018-12-25	8853700k	0

TotalLiability Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-.7	0

DebtEquityRatio

ReportDate	(AKCA)	(AKCA)
2017-12-25	201.4	0
2018-12-25	312.6	0

DebtEquityRatio Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	55.2	0

Cash Flow Benchmark | Key Ratio B | Income B | Balance B | Cash B | Top

OperatingCF

ReportDate	(AKCA)	(AKCA)
2017-12-25	-3619m	0
2018-12-25	-20288800k	0

OperatingCF Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-460.6	0

CAPEX

ReportDate	(AKCA)	(AKCA)
2017-12-25	-900k	0
2018-12-25	-111900k	0

CAPEX Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-12333.3	0

FreeCashFlow

ReportDate	(AKCA)	(AKCA)
2017-12-25	-3619900k	0
2018-12-25	-20400700k	0

FreeCashFlow Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-463.6	0

InvestmentFlow

ReportDate	(AKCA)	(AKCA)
2017-12-25	-20260800k	0
2018-12-25	7054500k	0

InvestmentFlow Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	134.8	0

FinancialFlow

ReportDate	(AKCA)	(AKCA)
2017-12-25	28940100k	0
2018-12-25	16283100k	0

FinancialFlow Trend

ReportDate	(AKCA)	(AKCA)
2018-12-25	-43.7	0

Note